Skip to main content
MDGL logo

MDGL · Madrigal Pharmaceuticals, Inc. · Held by Funds

Track MDGL — free
$379.10 -17.64 (-4.45%) At close · Nov 20 Play latest call Q3 2026 earnings call transcript
Market Cap
$8.81B
Shares
23.23M
Volume · Nov 20 327.92K Avg daily vol (3M) 367.24K

Registered funds — mutual funds, ETFs and closed-end funds — whose latest Form N-PORT portfolio report holds this exact listed security, matched by CUSIP. Each row is one fund position with its size, value and weight in that fund.

Fund Ownership of MDGL by Fund Type

Registered funds' Form N-PORT reports for the quarter ended Jun 30, 2026

Index funds and index ETFs hold 13.54% of shares outstanding.

Fund type Of shares outstanding Shares
Index funds 2.44% 566,002
Index ETFs 11.10% 2,578,620
Active ETFs 0.26% 60,393
Active funds 16.19% 3,761,476
Unclassified 0.31% 72,976
All registered funds 30.30% 7,039,467
How fund types are measured

Each fund series counts once, with its latest Form N-PORT report dated inside the quarter; only long share positions count, restated to today's split basis. The fund type is the series' latest Form N-CEN answer on or before the quarter end (the index-fund box and the exchange-traded flag), never its name. Unclassified funds have no usable N-CEN; unit investment trusts are among them, so index ownership is a floor. Funds sit inside their advisers' 13F reports, so these shares overlap the 13F figures and are never added to them.

Funds holding MDGL

392 fund positions
Fund Balance Value % of Fund Open
Showing 1–50 of 392 positions
Key facts CIK 1157601 CUSIP 558868105 13F (30d) 432 filings 393 filers Visit website Investor relations